Guy F. Cipriani - 10 Feb 2022 Form 4 Insider Report for AETHLON MEDICAL INC (AEMD)

Role
Sr. V.P., Chief Bus. Officer, Director
Signature
/s/ James B. Frakes, Attorney-in-Fact
Issuer symbol
AEMD
Transactions as of
10 Feb 2022
Net transactions value
$0
Form type
4
Filing time
11 Feb 2022, 12:56:08 UTC
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction AEMD Employee Stock Option (Right to Buy) Award $0 +100,200 $0.000000 100,200 10 Feb 2022 Common Stock 100,200 $1.41 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 25% of the shares subject to the stock option shall vest and become exercisable on February 10, 2023, and the remaining shares shall vest and become exercisable in 36 equal monthly installments thereafter.